Next Article in Journal
GamblingLess: A Randomised Trial Comparing Guided and Unguided Internet-Based Gambling Interventions
Next Article in Special Issue
The Chameleon Behavior of Sarcoidosis
Previous Article in Journal
Bleb Compressive Sutures in the Management of Hypotony Maculopathy after Glaucoma Surgery
Previous Article in Special Issue
Clinical Features and Diagnosis of Cardiac Sarcoidosis
 
 
Review

Novelties in Imaging of Thoracic Sarcoidosis

1
Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, 00168 Rome, Italy
2
Section of Radiology, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
3
Pulmonary Medicine Unit, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, 00168 Rome, Italy
*
Author to whom correspondence should be addressed.
Academic Editors: Philippe Guilpain and Cosima Schiavone
J. Clin. Med. 2021, 10(11), 2222; https://doi.org/10.3390/jcm10112222
Received: 15 April 2021 / Revised: 14 May 2021 / Accepted: 19 May 2021 / Published: 21 May 2021
(This article belongs to the Special Issue New Frontiers in the Diagnosis of Sarcoidosis)
Sarcoidosis is a systemic granulomatous disease affecting various organs, and the lungs are the most commonly involved. According to guidelines, diagnosis relies on a consistent clinical picture, histological demonstration of non-caseating granulomas, and exclusion of other diseases with similar histological or clinical picture. Nevertheless, chest imaging plays an important role in both diagnostic assessment, allowing to avoid biopsy in some situations, and prognostic evaluation. Despite the demonstrated lower sensitivity of chest X-ray (CXR) in the evaluation of chest findings compared to high-resolution computed tomography (HRCT), CXR still retains a pivotal role in both diagnostic and prognostic assessment in sarcoidosis. Moreover, despite the huge progress made in the field of radiation dose reduction, chest magnetic resonance (MR), and quantitative imaging, very little research has focused on their application in sarcoidosis. In this review, we aim to describe the latest novelties in diagnostic and prognostic assessment of thoracic sarcoidosis and to identify the fields of research that require investigation. View Full-Text
Keywords: sarcoidosis; HRCT; prognostic assessment; CXR; radiomics; chest MR sarcoidosis; HRCT; prognostic assessment; CXR; radiomics; chest MR
Show Figures

Figure 1

MDPI and ACS Style

Calandriello, L.; D’Abronzo, R.; Pasciuto, G.; Cicchetti, G.; del Ciello, A.; Farchione, A.; Strappa, C.; Manfredi, R.; Larici, A.R. Novelties in Imaging of Thoracic Sarcoidosis. J. Clin. Med. 2021, 10, 2222. https://doi.org/10.3390/jcm10112222

AMA Style

Calandriello L, D’Abronzo R, Pasciuto G, Cicchetti G, del Ciello A, Farchione A, Strappa C, Manfredi R, Larici AR. Novelties in Imaging of Thoracic Sarcoidosis. Journal of Clinical Medicine. 2021; 10(11):2222. https://doi.org/10.3390/jcm10112222

Chicago/Turabian Style

Calandriello, Lucio, Rosa D’Abronzo, Giuliana Pasciuto, Giuseppe Cicchetti, Annemilia del Ciello, Alessandra Farchione, Cecilia Strappa, Riccardo Manfredi, and Anna Rita Larici. 2021. "Novelties in Imaging of Thoracic Sarcoidosis" Journal of Clinical Medicine 10, no. 11: 2222. https://doi.org/10.3390/jcm10112222

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop